West Pharmaceutical Services Inc. (WST) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

West Pharmaceutical Servi...

NYSE: WST · Real-Time Price · USD
250.86
3.32 (1.34%)
At close: Sep 05, 2025, 3:59 PM
250.00
-0.34%
After-hours: Sep 05, 2025, 06:10 PM EDT

West Pharmaceutical Services Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.89B 2.95B 2.89B 2.83B
Cost of Revenue
1.89B 1.82B 1.75B 1.66B
Gross Profit
1B 1.13B 1.14B 1.17B
Operating Income
594.6M 710.9M 763.5M 758.7M
Interest Income
19.6M 28M 5.1M 1M
Pretax Income
600.2M 715.7M 700.6M 769M
Net Income
492.7M 593.4M 585.9M 661.8M
Selling & General & Admin
338.5M 353.4M 316.9M 361.9M
Research & Development
69.1M 68.4M 58.5M 52.8M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
407.6M 421.8M 375.4M 414.7M
Interest Expense
2.9M 8.8M 7.6M 8.5M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
2.3B 2.24B 2.12B 2.07B
Income Tax Expense
107.5M 122.3M 114.7M 107.2M
Shares Outstanding (Basic)
73M 74.3M 74.4M 74.4M
Shares Outstanding (Diluted)
73.7M 75.3M 75.8M 76.3M
EPS (Basic)
6.75 7.99 7.88 8.90
EPS (Diluted)
6.69 7.88 7.73 8.67
EBITDA
743.8M 844.1M 808.1M 879.7M
EBIT
588.4M 706.8M 687.5M 757.4M
Depreciation & Amortization
155.4M 137.3M 120.6M 122.3M